Moreover, the prevalence of hypertension was notably higher among patients with both normal and low albumin levels (92.86%, N = 26 and 86.05%, N = 37, respectively), with a p-value of 0.47. Similar trends were observed for dyslipidemia and heart disease, with p-values of 0.70 and 0.51, respectively, indicating no statistically significant differences based on albumin levels (Table 4). This evidence concerns the gene ALB and metabolic syndrome.